The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084380 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marco A Obregón-Mendoza und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: beta-Cyclodextrins, Curcumin, Antineoplastic Agents, Magnesium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UNAM DGAPA PAPIIT, Consejo Nacional de Humanidades, Ciencias y Tecnologías, CONAHCyT-FOINS-PRONACES.
Abstract (Originalsprache)
Breast cancer is one of the leading causes of death in the female population because of the resistance of cancer cells to many anticancer drugs used. Curcumin has cytotoxic activities against breast cancer cells, although it has limited use due to its poor bioavailability and rapid metabolic elimination. The synthesis of metal complexes of curcumin and curcuminoids is a relevant topic in the search for more active and selective derivatives of these molecular scaffolds. However, solubility and bioavailability are concomitant disadvantages of these types of molecules. To overcome such drawbacks, the preparation of inclusion complexes offers a chemical and pharmacologically safe option for improving the aqueous solubility of organic molecules. Herein, we describe the preparation of the inclusion complex of dimethoxycurcumin magnesium complex (DiMeOC-Mg, (4)) with beta-cyclodextrin (DiMeOC-Mg-BCD, (5)) in the stoichiometric relationship 1:1. This new inclusion complex’s solubility in aqueous media phosphate buffer saline (PBS) was improved by a factor of 6x over the free metal complex (4). Furthermore, 5 affects cell metabolic rate, cell morphology, cell migration, induced apoptosis, and downregulation of the matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9), interleukin-6 (IL-6), and signal transducer and activator of transcription-3 (STAT3) expression levels on MD Anderson metastasis breast-231 cancer (MDA-MB-231) cell lines. Results of an antitumor assay in an in ovo model showed up to 30% inhibition of tumor growth for breast cancer (MDA-MB-231) when using (5) (0.650 mg/kg dose) and 17.29% inhibition with the free homoleptic metal complex (1.5 mg/kg dose, (4)). While the formulation of inclusion complexes from metal complexes of curcuminoids demonstrates its usefulness in improving the solubility and bioavailability of these metallodrugs, the new compound (5) exhibits excellent potential for use as a therapeutic agent in the battle against breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Departamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, M. Wilfrido Massieu SN, U. A. Zacatenco, Mexico City 07738, Mexico.
- Departamento de Biología de la Reproducción "Dr. Carlos Gual Castro", Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
ORCID-Profile: Marco A Obregón-Mendoza, William Meza-Morales, Karla Daniela Rodríguez-Hernández, M Mirian Estévez-Carmona, Rosario Tavera-Hernández, David Barrera-Hernández, Brian Monroy-Torres, Antonio Nieto-Camacho
Förderung
- UNAM DGAPA PAPIIT
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- CONAHCyT-FOINS-PRONACES
- PAPIIT DGAPA
Zitieren
APA
Obregón-Mendoza, M. A., Meza-Morales, W., Rodríguez-Hernández, K. D., Estévez-Carmona, M. M., Pérez-González, L. L., Tavera-Hernández, R., Ramírez-Apan, M. T., Barrera-Hernández, D., García-Olivares, M., Monroy-Torres, B., Nieto-Camacho, A., Chávez, M. I., Sánchez-Obregón, R., & Enríquez, R. G. (2024). The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084380
Vancouver
Obregón-Mendoza MA, Meza-Morales W, Rodríguez-Hernández KD, Estévez-Carmona MM, Pérez-González LL, Tavera-Hernández R, et al. The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084380
BibTeX
@article{ObregnMendoza2024,
author = {Obregón-Mendoza, Marco A and Meza-Morales, William and Rodríguez-Hernández, Karla Daniela and Estévez-Carmona, M Mirian and Pérez-González, Leidys L and Tavera-Hernández, Rosario and Ramírez-Apan, María Teresa and Barrera-Hernández, David and García-Olivares, Mitzi and Monroy-Torres, Brian and Nieto-Camacho, Antonio and Chávez, María Isabel and Sánchez-Obregón, Rubén and Enríquez, Raúl G},
title = {The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084380}
}
EUVIMED